Automation is the process of using different control systems to perform a range of jobs in industries with little or no human interaction. Automation has moved into the pharmaceutical industry in recent years. Automation has been applied in the production, packing, labelling, and warehousing areas. The manufacture of specialised drugs is now possible because to the use of automated machinery. Utilising the most recent technologies has affected the R and D industry as well. The QA department's conventional responsibilities were limited to writing SOPs, carrying out audits and certifying and validating machinery and processes. The primary subjects of this study are the implementation of automated technology in the pharmaceutical industry and its implications for the division in charge of pharmaceutical quality assurance. This article covers the Raman probe along with other topics. Automation has been applied in the production, packing, labelling and warehousing areas. With the advent of automated machinery, the production of personalised drugs has become possible. Therefore, it's possible that automated systems could replace human inspectors. You can achieve greater repeatability and flexibility for less money with this technology.

The fast expansion of information and telecommunication technology has a significant impact on the delivery of healthcare in many nations. Geographical and demographic reasons, however, frequently result in rural inhabitants and communities having limited access to healthcare services. A more recent term for pharmaceutical service delivery is telepharmacy, which allows patients who live far from a hospital, pharmacy, or other healthcare facility to receive healthcare services from a qualified pharmacist, including medication review, patient counseling and prescription verification. Telepharmaceutical care is expected to keep growing as a result of improved resource allocation and more patient access, according to telemedicine trends. Numerous well-known advantages of telepharmacy include: Case of access to medical services in isolated and rural areas; financial gains; patient satisfaction due to medication availability and information in rural areas; efficient patient counseling; and minimal scarcity of local pharmacists and pharmacy services.